Cardionovum

Be up
to date.

Latest press release

Cardionovum experiences increase in demand for its innovative, and next generation „RESTORE Paclitaxel-releasing coronary balloon dilatation catheter.“ The American Journal of Cardiology, issue December 2015, published study results on the efficacy and safety of Paclitaxel coated balloon catheters for the treatment of in-stent restenosis in high risk patients. The RESTORE DEB showed significant superiority with lowest incidence of restenosis, if compared to other contemporary coronary DEBs.

Dr. Jean Paul de Vries (PI) presented the patient study results of the multi-center randomized RAPID trial.

Cardionovum prepares for a first international publication on 6-12 months FU patient results from the ongoing APERTO clinical study program. The APERTO Paclitaxel-releasing high pressure shunt balloon dilatation catheter was exclusively designed to treat shunt stenosis of hemodialysis patients.

Upcoming events

Cardionovum® at CIRSE 2024

Cardionovum® is pleased to invite you to visit us at booth #41.

Location:

CCL – Lisbon Congress Centre
Praça das Industrias 1
1300-307 Lisbon
Portugal

Date: Sep 14, 2024–Sep 18, 2024

Latest events

Cardionovum at SCR’17

Cardionovum participates at the Swiss Congress of Radiology SCR’17 Bern.

Date: June 08, 2017–June 10, 2017

Location: Kursaal Bern, Switzerland

Learn more >>

Visit website >>

Cardionovum EuroPCR exclusive event

Cardionovum customers deserve the best.
Exclusive Cardionovum event at EuroPCR 2017.

Date: May 17, 2017

Location: Maison de l'amérique latine, Paris, France

Learn more >>

Visit website >>

Cardionovum at Charing Cross

Cardionovum participates at Charing Cross.
You are welcome to visit us at booth no. 218.

Date: Apr 25, 2017–Apr 28, 2017

Location: London, UK

Learn more >>

Visit website >>

go top